|4Sep 9, 9:00 AM ET

Linscott Walt Addison 4

4 · Indaptus Therapeutics, Inc. · Filed Sep 9, 2022

Insider Transaction Report

Form 4
Period: 2022-09-07
Linscott Walt Addison
Chief Operating Officer
Transactions
  • Purchase

    Common stock

    2022-09-07$2.62/sh+150$393150 total

Documents

1 file
  • 4
    ownership.xmlPrimary